<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47027977PX-12 141400-58-0

    PX-12 141400-58-0

    簡要描述:PX-12 141400-58-0
    PX-12(IV-2) is an irreversible inhibitor of Thioredoxin-1(Trx-1) currently in clinical development as an antitumor agent; IC50=7 uM in Hela, MTT assay, 72 h.

    • 產(chǎn)品型號:abs47027977
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時(shí)間:2026-01-09
    • 訪  問  量:612

    詳細(xì)介紹

    品牌absinCAS141400-58-0
    分子式C7H12N2S2純度98%
    分子量188.32貨號abs47027977
    規(guī)格5mg供貨周期現(xiàn)貨
    主要用途is an irreversible inhibitor of Thioredo應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    PX-12 141400-58-0

    產(chǎn)品描述
    描述
    PX-12(IV-2) is an irreversible inhibitor of Thioredoxin-1(Trx-1) currently in clinical development as an antitumor agent; IC50=7 uM in Hela, MTT assay, 72 h.
    純度
    98%
    儲存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    別名
    PX12; PX 12; IV-2
    外觀
    類白色至褐色固體
    可溶性/溶解性
    DMSO : 18.8 mg/mL (100 mM);
    Ethanol : 38 mg/mL (201.79 mM)
    生物活性
    靶點(diǎn)
    Trx-1
    In vitro(體外研究)
    In MCF-7 and HT-29 cells, PX-12 prevents the hypoxia (1% oxygen)-induced increase in HIF-1alpha protein, and decreases HIF-1-trans-activating activity, VEGF formation, and inducible nitric oxide synthase. PX-12 also inhibits the growth of MCF-7 and HT-29 cells with IC50s of 1.9 μM and 2.9μM, respectively. PX-12 also inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase. In A549 cells, PX-12 inhibits cell growth via G2/M phase arrest, and Bax-mediated and ROS-dependent apoptosis. In hepatocelluar carcinoma cells, PX-12 exerts a synergistic effect with 5-FU to significantly suppress tumorigenicity.
    In vivo(體內(nèi)研究)
    In mice bearing MCF-7 tumor xenografts, PX-12 (12 mg/kg, i.p.) decreases HIF-1α and VEGF protein levels and microvessel density.
    參考文獻(xiàn)
    參考文獻(xiàn)
    • 1. Shin HR, et al. Oncol Lett. 2013 Dec;6(6):1804-1810.

    • 2. Baker AF, et al.J Lab Clin Med. 2006 Feb;147(2):83-90.

    研究領(lǐng)域
    研究領(lǐng)域
    Signal TransductionMetabolism
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    PX-12 141400-58-0溫馨提示:本產(chǎn)品僅作科研實(shí)驗(yàn)使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補(bǔ)充說明:

    • 驗(yàn)證碼:

      請輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號了解更多信息:
    歡迎您關(guān)注我們的微信公眾號
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    天堂网资源| 无码视频黄色 | 人成视频在线观看一区二区 | 日韩欧美国产A片 | 狠狠干干 |